Prevalence of Fabry Disease and Outcomes in Young Canadian Patients With Cryptogenic Ischemic Cerebrovascular Events
Author(s) -
Sylvain Lanthier,
Gustavo Saposnik,
Gerald Lebovic,
Karen L. Pope,
Daniel Selchen,
David F. Moore,
Dan Selchen,
Jean-Martin Boulanger,
Brian Buck,
Kenneth Butcher,
Martín del Campo,
Sylvie Gosselin,
Vladimir Hachinski,
Michael D. Hill,
Ariane Mackey,
Manu Mehdiratta,
J. David Spence,
Grant Stotts,
Rick Swartz,
Michael L. West,
Chidam Yegappan
Publication year - 2017
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.116.016083
Subject(s) - medicine , fabry disease , modified rankin scale , stroke (engine) , cohort , pediatrics , disease , diabetes mellitus , ischemic stroke , ischemia , mechanical engineering , engineering , endocrinology
Previous studies reported Fabry disease in 0% to 4% of young patients with cryptogenic ischemic stroke (IS). We sought to determine the prevalence of Fabry and outcomes among young Canadians with cryptogenic IS or transient ischemic attack (TIA).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom